[go: up one dir, main page]

FI895283A0 - Antikropp/laekemedelkonjugater. - Google Patents

Antikropp/laekemedelkonjugater.

Info

Publication number
FI895283A0
FI895283A0 FI895283A FI895283A FI895283A0 FI 895283 A0 FI895283 A0 FI 895283A0 FI 895283 A FI895283 A FI 895283A FI 895283 A FI895283 A FI 895283A FI 895283 A0 FI895283 A0 FI 895283A0
Authority
FI
Finland
Prior art keywords
laekemedelkonjugater
antikropp
Prior art date
Application number
FI895283A
Other languages
English (en)
Inventor
Russell Lavern Barton
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI895283A0 publication Critical patent/FI895283A0/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6883Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and unsaturated
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI895283A 1988-11-10 1989-11-07 Antikropp/laekemedelkonjugater. FI895283A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/269,815 US5010176A (en) 1988-11-10 1988-11-10 Antibody-drug conjugates

Publications (1)

Publication Number Publication Date
FI895283A0 true FI895283A0 (fi) 1989-11-07

Family

ID=23028765

Family Applications (1)

Application Number Title Priority Date Filing Date
FI895283A FI895283A0 (fi) 1988-11-10 1989-11-07 Antikropp/laekemedelkonjugater.

Country Status (16)

Country Link
US (2) US5010176A (fi)
EP (1) EP0368668B1 (fi)
JP (1) JPH02191300A (fi)
KR (1) KR900007408A (fi)
CN (1) CN1042546A (fi)
AU (1) AU619614B2 (fi)
CA (1) CA2000483A1 (fi)
DE (1) DE68927610T2 (fi)
DK (1) DK556689A (fi)
ES (1) ES2095840T3 (fi)
FI (1) FI895283A0 (fi)
HU (1) HU210147B (fi)
IL (1) IL92230A0 (fi)
NZ (1) NZ231302A (fi)
PT (1) PT92213B (fi)
ZA (1) ZA898434B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA914625B (en) * 1990-06-22 1993-02-24 Lilly Co Eli In vivo targeting with bifunctional antibodies
ES2049656B1 (es) * 1992-10-08 1994-11-16 Lilly Co Eli Grupos de conjugados de farmacos con anticuerpos.
US5556623A (en) * 1993-03-30 1996-09-17 Eli Lilly And Company Antibody-drug conjugates
JPH072895A (ja) * 1993-04-28 1995-01-06 Eli Lilly & Co 抗体−薬物複合体
US20030119724A1 (en) * 1995-11-22 2003-06-26 Ts`O Paul O.P. Ligands to enhance cellular uptake of biomolecules
US6521431B1 (en) 1999-06-22 2003-02-18 Access Pharmaceuticals, Inc. Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
CN1110322C (zh) * 1999-07-21 2003-06-04 中国医学科学院医药生物技术研究所 单克隆抗体Fab'-平阳霉素偶联物及其抗肿瘤作用
EP1355672A2 (en) 2000-12-01 2003-10-29 Cell Works Inc. Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use
US6441163B1 (en) 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
FR2862134B1 (fr) * 2003-11-12 2007-07-27 Sebia Sa Analyse et typage de proteines monoclonales par electrophorese capillaire et immunodeplacement
DE102006037786A1 (de) 2006-08-11 2008-03-20 Resprotect Gmbh Nukleoside, diese enthaltendes Arzneimittel und deren Verwendung
US7825267B2 (en) * 2006-09-08 2010-11-02 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Synthesis of FR901464 and analogs with antitumor activity
EP3492488A1 (en) 2007-08-22 2019-06-05 The Regents of The University of California Activatable binding polypeptides and methods of identification and use thereof
EP2042496A1 (de) * 2007-09-18 2009-04-01 Bayer CropScience AG Verfahren zur Herstellung von 4-Aminobut-2-enoliden
BRPI1006141B8 (pt) 2009-01-12 2021-05-25 Cytomx Therapeutics Llc composições de anticorpo modificado, métodos para preparar e usar as mesmas
CA2753294A1 (en) 2009-02-23 2010-08-26 Cytomx Therapeutics, Inc. Proproteins and methods of use thereof
US9771377B2 (en) 2012-12-21 2017-09-26 University of Pittsburgh—of the Commonwealth System of Higher Education Synthesis of FR901464 and analogs with antitumor activity
MX2018014927A (es) 2016-06-02 2019-04-09 Abbvie Inc Agonista del receptor de glucocorticoides e inmumoconjugados del mismo.
MA49796A (fr) 2017-12-01 2020-06-03 Abbvie Inc Agoniste du récepteur des glucocorticoïdes et immunoconjugués de celui-ci
CN114874214B (zh) * 2022-05-31 2023-03-21 南京航空航天大学 可偶联巯基的双功能大环螯合剂衍生物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3905871A (en) * 1971-05-14 1975-09-16 Syva Co Lactam conjugates to enzymes
DE2635841C2 (de) * 1976-08-10 1983-02-24 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur Herstellung von Alkoxymethylenmalonsäurenitrilen
US4230805A (en) * 1977-04-15 1980-10-28 Syva Company Theophylline antigens and antibodies
US4631190A (en) * 1981-06-26 1986-12-23 Shen Wei C Acidity-sensitive spacer molecule to control the release of pharmaceuticals from molecular carriers
US4671958A (en) * 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
GB2181126B (en) * 1983-03-30 1987-08-26 Lilly Industries Ltd Novel pharmaceutical compounds
DK167884A (da) * 1983-03-30 1984-10-01 Lilly Industries Ltd Immunoglobulinkonjugater
US4695624A (en) * 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4764368A (en) * 1984-08-29 1988-08-16 Dana-Farber Cancer Institute, Inc. Acid-cleavable compound
US4762915A (en) * 1985-01-18 1988-08-09 Liposome Technology, Inc. Protein-liposome conjugates
GB8610551D0 (en) * 1986-04-30 1986-06-04 Hoffmann La Roche Polypeptide & protein derivatives
IL82579A0 (en) * 1986-05-27 1987-11-30 Lilly Co Eli Immunoglobulin conjugates
US4997913A (en) * 1986-06-30 1991-03-05 Oncogen pH-sensitive immunoconjugates and methods for their use in tumor therapy
US4793986A (en) * 1987-02-25 1988-12-27 Johnson Matthey, Inc. Macromolecular platinum antitumor compounds
US5028697A (en) * 1988-08-08 1991-07-02 Eli Lilly And Company Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers
GB8903021D0 (en) * 1989-02-10 1989-03-30 Celltech Ltd Chemical compounds

Also Published As

Publication number Publication date
EP0368668A3 (en) 1992-10-07
DE68927610T2 (de) 1997-05-15
JPH02191300A (ja) 1990-07-27
EP0368668B1 (en) 1997-01-02
CN1042546A (zh) 1990-05-30
HU210147B (en) 1995-02-28
US5010176A (en) 1991-04-23
HU895847D0 (en) 1990-01-28
US5514794A (en) 1996-05-07
NZ231302A (en) 1992-11-25
HUT53126A (en) 1990-09-28
ES2095840T3 (es) 1997-03-01
DK556689A (da) 1990-05-14
AU4451389A (en) 1990-06-28
KR900007408A (ko) 1990-06-01
PT92213A (pt) 1990-05-31
PT92213B (pt) 1995-07-06
EP0368668A2 (en) 1990-05-16
AU619614B2 (en) 1992-01-30
DK556689D0 (da) 1989-11-08
DE68927610D1 (de) 1997-02-13
ZA898434B (en) 1991-07-31
CA2000483A1 (en) 1990-05-10
IL92230A0 (en) 1990-07-26

Similar Documents

Publication Publication Date Title
DE68906637D1 (de) Wafertraeger.
FI880043A0 (fi) Lastenhet.
DE68921898D1 (de) Ringbinder.
DE58904326D1 (de) Rakelfarbwerk.
FI895283A0 (fi) Antikropp/laekemedelkonjugater.
FI894123A0 (fi) Centrifugroer.
FI891491A0 (fi) Omaettade n-benzopyranyllaktamer.
DE68909215D1 (de) Laseroszillator.
FI894124L (fi) Fluorsubstituerade epipodofyllotoxinglukosider.
NO893198D0 (no) Benzopyranolderivater.
FI890143A (fi) Skaer foer flaomaskin.
FI891892A0 (fi) N-substituerade n-aminopyrroler.
FI895166A0 (fi) Vattenlaos.
FI83400B (fi) Faestningsklaemma.
FI911843A0 (fi) Stoeldskyddsanordning.
FI895705A0 (fi) Hydrodynamisk koppling.
FI894780A0 (fi) Kontroll- och vaerderingssystem foer froesaodd.
ES1007733Y (es) Arqueta.
FI80861B (fi) Plastdosa.
ES1013066Y (es) Cantonera.
FI83355B (fi) Loksnoeplog.
DE68905332D1 (de) Azoxy - verbindung.
ES1004162Y (es) Salero-pimentero.
ES1005477Y (es) Braga-compresa.
ES1006297Y (es) Atadura-precinto.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: ELI LILLY AND COMPANY